Ablation Technologies Market worth 4.73 Billion USD by 2021
This report studies the global Ablation Technology Market over the forecast period of 2016 to 2021. The market is expected to reach USD 4.73 Billion by 2021, at a CAGR of 10.9% from 2016 to 2021.
A number of factors such as an increasing number of ablation procedures, growing prevalence of target diseases including cancer and cardiovascular diseases, the emergence of next-generation ablation products...
Apheresis Market worth 2.06 Billion USD by 2021
The Global Apheresis Market is projected to reach USD 2.06 Billion by 2021, at a CAGR of 7.7% from 2016 to 2021.
The rising incidence of chronic lifestyle diseases such as diabetes, kidney disorders, & respiratory diseases, increasing demand for blood components, and favorable reimbursement scenario are the key factors driving the growth of the market. However, scarcity of qualified donors and...
Injectable Drug Delivery Market worth 624.50 Billion USD by 2021
The global Injectable Drug Delivery Market, in terms of value, is projected to reach USD 624.50 Billion by 2021 from USD 362.38 Billion in 2016, at a CAGR of 11.5% during the forecast period.
Growth in this market is mainly driven by increasing prevalence of chronic diseases, rising aging population, increasing use of biologics, and increasing number of needlestick injuries. On the other hand, growing...
Drug Delivery Technology Market worth 1,669.40 Billion USD by 2021
Drug Delivery Technology Market is projected to reach USD 1,669.40 Billion by 2021 from USD 1,179.20 Billion in 2016, at a CAGR of 7.2% during the forecast period.
Increasing prevalence of chronic diseases, increasing demand for biologics, technological advancements, and new product launches are some of the major factors driving the growth of the drug delivery technology market. Furthermore, self-administration...
Antibody Production Market worth 13.28 Billion USD by 2021
This report studies the Antibody Production Market for the forecast period of 2016 to 2021. This market is expected to reach USD 13.28 Billion by 2021 from USD 7.45 Billion in 2016, at a CAGR of 12.3%.
A number of factors such as the improved approval rate for therapeutic antibodies by regulatory authorities, patent expiry of blockbuster monoclonal antibodies, increasing adoption of targeted immunotherapy,...
Medical Animation Market – Emerging Trends & Global Industry Forecast to 2021
Drivers:
# Rising Adoption of Medical Animation By Life Science & Medical Device Companies
# Entry of Start-Ups in the Medical Animation Market
# Growing Pharmaceutical/Biopharmaceutical and Medical Devices Industry
# Increasing Penetration of Smartphones, Tablets, and Other Mobile Platforms
# Rising Geriatric Population and Growing Number of Surgeries Globally
Restraint:
# High Cost of Medical...
HIV Diagnosis Market Worth $3.88 Billion by 2021
According to a new market research report “HIV Diagnosis Market by Test Type (Antibody (ELISA, Rapid, Western Blot), Viral Load, CD4 Count, Early Infant, Viral Identification), Product (Assay, Kit, Reagent, Instrument, Software, Services), End User (Hospitals) – Global Forecast to 2021” published by MarketsandMarkets, the market is projected to reach USD 3.88 Billion by 2021 from...
Electroceuticals / Bioelectric Medicine Market – Emerging Trends | Global Forecast to 2021
Objectives of the Study:
# To define and measure the global Electroceuticals Market with respect to product, type of device, application, end user and region
# To identify key micromarkets and their drivers within the global electroceuticals/bioelectric medicine market, which are expected to show growth opportunities in the coming years
# To analyze opportunities in the market for stakeholders and...
Electrophoresis Gels Accounted for the Largest Share of the Global Electrophoresis Reagents Market
Secondary Research:
In the secondary research process, various secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dun & Bradstreet have been referred to, so as to identify and collect information for this study. These secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors,...
Product Enhancements, Agreements, and Partnerships were the Most Widely Adopted Growth Strategies by the Players in the Clinical Trial Management System Market
The global Clinical Trial Management System (CTMS) Market is expected to grow at a CAGR of 12.6% between 2017 and 2022. Factors such as significant partnerships between biopharma companies and CROs, rising number of clinical trials, availability of advanced CTMS solutions, growing customer base for CTMS solutions, and rising government funding & grants to support clinical trials are driving the...